These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24913241)

  • 41. Medication cost is significantly reduced after Roux-en-Y gastric bypass in obese patients.
    Gesquiere I; Aron-Wisnewsky J; Foulon V; Haggege S; Van der Schueren B; Augustijns P; Bouillot JL; Clement K; Basdevant A; Oppert JM; Buyse M
    Obes Surg; 2014 Nov; 24(11):1896-903. PubMed ID: 24947346
    [TBL] [Abstract][Full Text] [Related]  

  • 42. One-year Surgical Outcomes and Costs for Medicaid Versus Non-Medicaid Patients Undergoing Laparoscopic Roux-en-Y Gastric Bypass: A Single-Center Study.
    Chen EY; Fox BT; Suzo A; Greenberg JA; Campos GM; Garren MJ; Funk LM
    Surg Laparosc Endosc Percutan Tech; 2016 Feb; 26(1):38-43. PubMed ID: 26836627
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in Spain.
    Shearer AT; Bagust A; Ampudia-Blasco FJ; Martínez-Lage Alvarez B; Pérez Escolano I; París G
    Pharmacoeconomics; 2006; 24 Suppl 1():49-59. PubMed ID: 16800162
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bariatric surgery: a systematic review of the clinical and economic evidence.
    Padwal R; Klarenbach S; Wiebe N; Hazel M; Birch D; Karmali S; Sharma AM; Manns B; Tonelli M
    J Gen Intern Med; 2011 Oct; 26(10):1183-94. PubMed ID: 21538168
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-utility analysis comparing laparoscopic vs open aortobifemoral bypass surgery.
    Krog AH; Sahba M; Pettersen EM; Wisløff T; Sundhagen JO; Kazmi SS
    Vasc Health Risk Manag; 2017; 13():217-224. PubMed ID: 28670132
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-Effectiveness of Total Knee Arthroplasty vs Nonoperative Management in Normal, Overweight, Obese, Severely Obese, Morbidly Obese, and Super-Obese Patients: A Markov Model.
    Ponnusamy KE; Vasarhelyi EM; Somerville L; McCalden RW; Marsh JD
    J Arthroplasty; 2018 Jul; 33(7S):S32-S38. PubMed ID: 29550168
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of gastric bypass patients 1 year after surgery: changes in quality of life and obesity-related conditions.
    Sears D; Fillmore G; Bui M; Rodriguez J
    Obes Surg; 2008 Dec; 18(12):1522-5. PubMed ID: 18566865
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Results of Roux-en-Y gastric bypass in morbidly obese vs superobese patients: similar body weight loss, correction of comorbidities, and improvement of quality of life.
    Suter M; Calmes JM; Paroz A; Romy S; Giusti V
    Arch Surg; 2009 Apr; 144(4):312-8; discussion 318. PubMed ID: 19380643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-utility analysis for bariatric surgery compared with usual care for the treatment of obesity in Australia.
    James R; Salton RI; Byrnes JM; Scuffham PA
    Surg Obes Relat Dis; 2017 Dec; 13(12):2012-2020. PubMed ID: 28237564
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Two-year changes in health-related quality of life in gastric bypass patients compared with severely obese controls.
    Kolotkin RL; Crosby RD; Gress RE; Hunt SC; Adams TD
    Surg Obes Relat Dis; 2009; 5(2):250-6. PubMed ID: 19306822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Economic evaluation of surgical treatment of obesity.
    Rodicio Miravalles JL; Alonso Fernández J; Moreno Gijón M; Rizzo Ramos A; Turienzo Santos E; Sanz Álvarez L; Rodríguez García JI; González González JJ
    Cir Esp (Engl Ed); 2020; 98(7):381-388. PubMed ID: 32139086
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Costs of bariatric surgery in a randomised control trial (RCT) comparing Roux en Y gastric bypass vs sleeve gastrectomy in morbidly obese diabetic patients.
    Gounder ST; Wijayanayaka DR; Murphy R; Armstrong D; Cutfield RG; Kim DD; Clarke MG; Evennett NJ; Humphreys ML; Robinson SJ; Booth MW
    N Z Med J; 2016 Oct; 129(1443):43-52. PubMed ID: 27736851
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bariatric surgery for severely obese adolescents.
    Sugerman HJ; Sugerman EL; DeMaria EJ; Kellum JM; Kennedy C; Mowery Y; Wolfe LG
    J Gastrointest Surg; 2003 Jan; 7(1):102-108. PubMed ID: 12559191
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity (AMOS): a prospective, 5-year, Swedish nationwide study.
    Olbers T; Beamish AJ; Gronowitz E; Flodmark CE; Dahlgren J; Bruze G; Ekbom K; Friberg P; Göthberg G; Järvholm K; Karlsson J; Mårild S; Neovius M; Peltonen M; Marcus C
    Lancet Diabetes Endocrinol; 2017 Mar; 5(3):174-183. PubMed ID: 28065734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-effectiveness analysis of laparoscopic gastric bypass, adjustable gastric banding, and nonoperative weight loss interventions.
    Salem L; Devlin A; Sullivan SD; Flum DR
    Surg Obes Relat Dis; 2008; 4(1):26-32. PubMed ID: 18069075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-Effectiveness of Bariatric Surgery Prior to Total Knee Arthroplasty in the Morbidly Obese: A Computer Model-Based Evaluation.
    McLawhorn AS; Southren D; Wang YC; Marx RG; Dodwell ER
    J Bone Joint Surg Am; 2016 Jan; 98(2):e6. PubMed ID: 26791039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of open and laparoscopic Roux-en-Y gastric bypass surgery for morbid and super obesity: a decision-analysis model.
    Siddiqui A; Livingston E; Huerta S
    Am J Surg; 2006 Nov; 192(5):e1-7. PubMed ID: 17071173
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prescription drug cost reduction in Native Hawaiians after laparoscopic Roux-en-y gastric bypass.
    Lam EC; Murariu D; Takahashi E; Park CW; Bueno RS; Lorenzo CS
    Hawaii J Med Public Health; 2013 Feb; 72(2):40-3. PubMed ID: 23467573
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The real-world cost-effectiveness of bariatric surgery for the treatment of severe obesity: a cost-utility analysis.
    Lester ELW; Padwal RS; Birch DW; Sharma AM; So H; Ye F; Klarenbach SW
    CMAJ Open; 2021; 9(2):E673-E679. PubMed ID: 34145050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and cost effectiveness of surgery for morbid obesity: a systematic review and economic evaluation.
    Clegg A; Colquitt J; Sidhu M; Royle P; Walker A
    Int J Obes Relat Metab Disord; 2003 Oct; 27(10):1167-77. PubMed ID: 14513064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.